Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
PR Newswire, Tuesday, 3 December 1996, 1:39 P.M.
Serostim(TM), produced by Serono Laboratories, was approved by the U.S. Food and Drug Administration (FDA) on Aug. 26, 1996. It has been proven effective for the treatment of AIDS wasting or cachexia, a leading cause of death among people with AIDS. AIDS wasting causes the body to inappropriately burn lean body mass (LBM), including muscle and organ tissue, instead of fat.
Serostim(TM) therapy prevents continued LBM loss and promotes build up of LBM -- which distinguishes Serostim(TM) from any other AIDS drug on the market -- while dramatically improving physical functions.
"Priority Pharmacy is tremendously excited to be a part of this scientific breakthrough that will benefit the entire AIDS community," Zeiger said. "Our main goal is to improve the lives of people living with AIDS, and this drug will lend additional strength in the fight against this epidemic."
Priority Pharmacy has also been heavily involved in assisting other high- maintenance, high-risk groups, including cancer, transplant, pulmonary, cardiac and renal patients. Specializing in overnight, confidential delivery of acute and maintenance medications, Priority Pharmacy has evolved from a retail pharmacy to the largest specialty home-delivery prescription service west of the Mississippi.
In addition to its convenient home-delivery service, Priority also handles all insurance billing while "fronting" the cost of medication until payment is received from the insurance company, thus sparing the client out-of-pocket expenses. Always responsive to the patients' needs, Priority provides clinical pharmacists who respond to clients' questions by phone or in person. A computerized record of every client's drug history is maintained to provide quick response, thus avoiding adverse drug interactions. For more information on Serostim(TM), call Priority Pharmacy at 800-487-7115.
Serono Laboratories, Inc. is the United States member of The Ares-Serono Group of companies, the world's foremost developer and manufacturer of pharmaceuticals for treatment of infertility. Ares-Serono also specializes in the development, production and marketing of pharmaceutical products in the area of growth and metabolism and immunology/oncology. SOURCE Priority Pharmacy
961203
PR961207
Copyright © 1996 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .